Delivery Order SPE2DB22D3301-SPE2DB26FX3YL
Award Date 10/28/25
Potential Completion Date 10/29/25
Potential Value $5.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Xeljanz 5 mg tablets (60-count units) with a ceiling value of $3,175.22. This non-set-aside, firm fixed price delivery order is set to be completed by November 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's critical role as a pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,074.77 to AmerisourceBergen Drug Corp for the supply of Xeljanz 5 mg tablets (60-count units). This non-competitive delivery order, issued on April 22, 2025, with completion by April 23, 2025, represents a firm fixed-price transaction under DLA's pharmaceutical procurement framework. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order valued at $3,012.98 to AmerisourceBergen Drug Corp for the supply of Xeljanz 5 mg tablets (60-count units) on September 11, 2025, with completion anticipated by September 12, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $18,191.81 to AmerisourceBergen Drug Corp for the supply of Xeljanz 5 mg tablets (60-count units) on August 25, 2025, with an ultimate completion date of August 26, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a direct fulfillment of pharmaceutical supply needs for federal medical procurement. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,913.51 to AmerisourceBergen Drug Corp for the supply of Xeljanz 5 mg tablets (60-count units) with an ultimate completion date of August 12, 2025. The contract employs firm fixed-price pricing and carries no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $22,533.49 to AmerisourceBergen Drug Corp for Xeljanz XR 11 mg tablets (30-count units) on September 17, 2025, with an ultimate completion date of September 18, 2025. This firm fixed price delivery order was competitively awarded without any set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical supply transaction within DLA's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $73,540.08 to AmerisourceBergen Drug Corp for the supply of Xeljanz XR 11 mg tablets (30-count units) with a completion deadline of April 30, 2025. This competitively awarded, firm fixed-price contract was issued on April 29, 2025, with no set-aside designation. The order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Xeljanz 5 mg tablets (60-count units) with a ceiling value of $4,948.41. This firm fixed price delivery order, which is expected to be completed by August 19, 2025, represents a non-set-aside, competitively awarded contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Xeljanz 5 mg tablets (60-count units) with a contract value of $15,381.86. This is a firm fixed-price delivery order with an ultimate completion date of November 4, 2025, and represents a non-competitive award under an existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that serves as a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,432.97 for Xeljanz 5 mg tablets (60-count units) on September 17, 2025, with completion scheduled for September 18, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at the contractor's facility in Conshohocken, Pennsylvania,...